Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Presentation TCT 2019

Machine Learning Modelling vs. STS/ACC-TVT Score to Predict Mortality After Transcatheter Aortic Valve Replacement

Presenter: Pavel Overtchouk

September 26, 2019

Presentation TCT 2018

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Wojtek Wojakowski, Mirvat Alasnag, Ori Ben-Yehuda, Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Mohamed Ahmed Sobhy, Pedro de Araujo Goncalves

September 23, 2018

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

Advertisement

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

What’s Going to Be Big at TCT 2024?

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

New Faces, New Formats, New Tech: What to Expect From TCT 2022

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Machine Learning Modelling vs. STS/ACC-TVT Score to Predict Mortality After Transcatheter Aortic Valve Replacement

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content